Skip to content
No picture yet

Ibrance 75 mg – DIN 02493535

Ibrance is Palbociclib 75 mg (tablet), sold in Canada. It is used for breast cancer. It is supplied by Pfizer Canada ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Palbociclib 75 mg

Brand
Ibrance
Strength
75 mg
Used for
Breast cancer
Form
Tablet
Manufacturer
Pfizer Canada ULC
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02493535

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Palbociclib pills and guides

What is Palbociclib used for?

Palbociclib is used for breast cancer.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

HER2-Negative Metastatic Breast Cancer

IBRANCE is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:

  • an aromatase inhibitor as initial endocrine-based therapy; or
  • fulvestrant in patients with disease progression following endocrine therapy.

IBRANCE is indicated in combination with inavolisib and fulvestrant for the treatment of adult patients with endocrine-resistant, PIK3CA-mutated, HR-positive, HER2-negative, locally advanced or metastatic breast cancer, as detected by an FDA-authorized test, following recurrence on or after completing adjuvant endocrine therapy.

HER2-Positive Metastatic Breast Cancer

IBRANCE is indicated in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of adult patients with HR-positive, HER2-positive locally advanced or metastatic breast cancer following induction treatment.

From the FDA-approved label on DailyMed (published Jul 09, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02493535.
  • It names Ibrance, Palbociclib 75 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as Ibrance by Pfizer Canada ULC.

In Canada: prescription only.

Ingredients

Active: Palbociclib

Other Palbociclib pills